AAAAAA

   
Results: 1-7 |
Results: 7
TENOXICAM, A NONSTEROID ANTIINFLAMMATORY DRUG, IS UNABLE TO INCREASE THE RESPONSE RATE IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED BY ALPHA-INTERFERON
Authors: ZARSKI JP MAYNARDMUET M CHOUSTERMAN S BAUD M BARNOUD R ABERGEL A BACQ Y COMBIS JM CAUSSE X TRAN A OBERTI F MINELLO A BRESSONHADNI S BAILLY F RAABE JJ LEROY V HAMICI L HICHAM T GIRARDIN MFS
Citation: Jp. Zarski et al., TENOXICAM, A NONSTEROID ANTIINFLAMMATORY DRUG, IS UNABLE TO INCREASE THE RESPONSE RATE IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED BY ALPHA-INTERFERON, Hepatology, 27(3), 1998, pp. 862-867
ROLE OF ANTIINTERFERON ANTIBODIES IN BREAKTHROUGH OCCURRENCE DURING ALPHA-2A AND ALPHA-2B THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: LEROY V BAUD M DETRAVERSAY C MAYNARDMUET M LEBON P ZARSKI JP
Citation: V. Leroy et al., ROLE OF ANTIINTERFERON ANTIBODIES IN BREAKTHROUGH OCCURRENCE DURING ALPHA-2A AND ALPHA-2B THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C, Journal of hepatology, 28(3), 1998, pp. 375-381
PREVALENCE AND SIGNIFICANCE OF ANTICARDIOLIPIN, ANTI-BETA(2) GLYCOPROTEIN-I AND ANTI-PROTHROMBIN ANTIBODIES IN CHRONIC HEPATITIS-C
Authors: LEROY V ARVIEUX J JACOB MC MAYNARDMUET M BAUD M ZARSKI JP
Citation: V. Leroy et al., PREVALENCE AND SIGNIFICANCE OF ANTICARDIOLIPIN, ANTI-BETA(2) GLYCOPROTEIN-I AND ANTI-PROTHROMBIN ANTIBODIES IN CHRONIC HEPATITIS-C, British Journal of Haematology, 101(3), 1998, pp. 468-474
EFFICACY OF ALPHA-INTERFERON IN CHRONIC H EPATITIS-C PATIENTS NON RESPONDER TO A FIRST TREATMENT - A PILOT PROSPECTIVE AND RANDOMIZED TRIAL
Authors: ROLACHON A KEZACHIAN G CAUSSE X BAUD M LEROY V MAYNARDMUET M PASQUIER D ZARSKI JP
Citation: A. Rolachon et al., EFFICACY OF ALPHA-INTERFERON IN CHRONIC H EPATITIS-C PATIENTS NON RESPONDER TO A FIRST TREATMENT - A PILOT PROSPECTIVE AND RANDOMIZED TRIAL, Gastroenterologie clinique et biologique, 21(12), 1997, pp. 924-928
NON STEROID ANTIINFLAMMATORY DRUGS ARE NOT ABLE TO INCREASE THE RESPONSE RATE IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED BY INTERFERON-ALPHA - A RANDOMIZED CONTROLLED TRIAL
Authors: ZARSKI JP MAYNARDMUET M CHOUSTERMAN S BAUD M BARNOUD R ABERGEL A BACQ Y COMBIS JM CAUSSE X TRAN A OBERTI F MINELLO A BRESSONHADNI S BAILLY F RAABE JJ HAMICI L HICHAM T GIRARDIN MFS
Citation: Jp. Zarski et al., NON STEROID ANTIINFLAMMATORY DRUGS ARE NOT ABLE TO INCREASE THE RESPONSE RATE IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED BY INTERFERON-ALPHA - A RANDOMIZED CONTROLLED TRIAL, Hepatology, 26(4), 1997, pp. 358-358
ROLE OF NEUTRALIZING ANTI INTERFERON ANTIBODIES IN BREAKTHROUGH OCCURRENCE DURING ALPHA-2A AND ALPHA-2B THERAPY IN CHRONIC HEPATITIS-C PATIENTS
Authors: LEROY V BAUD M DETRAVERSAY C MAYNARDMUET M LEBON P ZARSKI JP
Citation: V. Leroy et al., ROLE OF NEUTRALIZING ANTI INTERFERON ANTIBODIES IN BREAKTHROUGH OCCURRENCE DURING ALPHA-2A AND ALPHA-2B THERAPY IN CHRONIC HEPATITIS-C PATIENTS, Hepatology, 26(4), 1997, pp. 705-705
PREVALENCE AND SIGNIFICANCE OF ANTICARDIOLIPIN AND ANTIPHOSPHOLIPID COFACTORS ANTIBODIES IN CHRONIC HEPATITIS-C/
Authors: LEROY V ARVIEUX J JACOB MC MAYNARDMUET M BAUD M ZARSKI JP
Citation: V. Leroy et al., PREVALENCE AND SIGNIFICANCE OF ANTICARDIOLIPIN AND ANTIPHOSPHOLIPID COFACTORS ANTIBODIES IN CHRONIC HEPATITIS-C/, Hepatology, 26(4), 1997, pp. 1678-1678
Risultati: 1-7 |